Next Article in Journal
Potential Clinical Impact of LAFOV PET/CT: A Systematic Evaluation of Image Quality and Lesion Detection
Previous Article in Journal
Reinforcement-Learning-Based Localization of Hippocampus for Alzheimer’s Disease Detection
 
 
Article
Peer-Review Record

A Benchmark of In-House Homologous Recombination Repair Deficiency Testing Solutions for High-Grade Serous Ovarian Cancer Diagnosis

Diagnostics 2023, 13(21), 3293; https://doi.org/10.3390/diagnostics13213293
by Rodrigo Guarischi-Sousa *,†, José Eduardo Kroll †, Adriano Bonaldi, Paulo Marques Pierry, Darine Villela, Camila Alves Souza, Juliana Santos Silva, Matheus Carvalho Bürger, Felipe Azevedo Oliveira, Marcelo Gomes de Paula, Fabiana Marcelino Meliso, Luiz Gustavo de Almeida, Priscilla Morais Monfredini, Ana Gabriela de Oliveira, Fernanda Milanezi, Cristovam Scapulatempo-Neto and Guilherme Lopes Yamamoto
Reviewer 1:
Diagnostics 2023, 13(21), 3293; https://doi.org/10.3390/diagnostics13213293
Submission received: 17 July 2023 / Revised: 24 August 2023 / Accepted: 28 August 2023 / Published: 24 October 2023
(This article belongs to the Special Issue Advanced Role of Genetic Biomarkers in Clinical Diagnostics)

Round 1

Reviewer 1 Report

1.      What's the time you conduct this examination in clinical practice?

2.      What's the economic benefit of your own examination?

3.      What's do you suggest conducting HRD examination in clinical practice in Brazil?

4.      Do you think your in-house HRD examination can become global commercially available tool?

Author Response

Please see the file attached below.

Author Response File: Author Response.pdf

Reviewer 2 Report

I read with great interest the manuscript, which falls within the aim of this Journal and offers a high-quality overview of the topic.  

Methodology is accurate and conclusions are supported by the data analysis. The discussions sufficiently answer the following questions: main findings of the study, strengths and Limitations of the study, implications and comparison with literature, and future directions.

Although the manuscript can be considered already of high quality, I would suggest taking into account the following minor recommendations:

 

- I suggest another language revision round to correct a few typos and improve readability.

 

- I find it interesting to include a reference to the screening programs for early cervical cancer diagnosis (Golia D'Augè T, Giannini A, Bogani G, Di Dio C, Laganà AS, Di Donato V, Salerno MG, Caserta D, Chiantera V, Vizza E, Muzii L, D’Oria O. Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives. Clin. Exp. Obstet. Gynecol. 2023, 50(8), 160. https://doi.org/10.31083/j.ceog5008160).

- Authors can consider PMID: 37314974 to have some insights.

 

Considering all these points, I think it could be of interest to the readers and, in my opinion, it deserves the priority to be published pending a few minor revisions.

 

 

Minor editing of English language required to make the work clearer and more readable.

 

Author Response

Please see the file attached below.

Author Response File: Author Response.pdf

Back to TopTop